• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Taiwan·Consumer Cyclical·2705.TW
Share

Leofoo Development Co., Ltd. Stocks

NT$ 16.2Last Updated 27.07.2026

Issuer Rating

3/7
Performance

Average

Risk

Considerable

Recommendation

Sell

Market Cap

NT$ 96.78M

NT$ 16.2
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Leofoo Development Co., Ltd. is a Taiwanese enterprise primarily involved in the tourism and hospitality sector. The company manages a diverse portfolio of accommodation and leisure facilities, including prominent hotel brands like the Leofoo Hotel and the Courtyard by Marriott Taipei, alongside the unique apartment-style boutique hotel, Leofoo Residences. Beyond lodging, Leofoo operates popular entertainment venues such as the Leofoo Village theme park, the Leofoo Water Park, and the resort property known as Leofoo Resort Guanshi. Its operations also extend to the food and beverage industry, managing bakeries under the Elite Bakery and Elite Concept brands. Established in 1968, the company maintains its headquarters in Hsinchu, Taiwan.

Company Valuation

Slightly undervalued
5/7

Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. In particular, the stock is reasonably priced on P/E, 'expensive' on EV/EBITDA, un

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

27.07.2026 22:30

Oncology drugs helped boost AstraZeneca's profits by 21%. Will the company expand its portfolio?

27.07.2026 22:13

Plata has appointed the former U.S. ambassador to Russia to its board of directors

27.07.2026 21:56

Bank of America announced the temporary closure of its positions in Kazakh government bonds

27.07.2026 21:42

Nvidia has invested in Ilya Sutskever's AI startup. Why is it doing this?

27.07.2026 21:17

Shares of U.S. chipmakers plummeted following the IPO of a Chinese competitor

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026